9 | Aromatase (CYP19)IBA
09/2008
-
07/2002 |
4 | CarcinogensIBA
01/2018
-
08/2003 |
4 | hydroxide ionIBA
04/2010
-
12/2005 |
4 | Halogenated Diphenyl EthersIBA
04/2010
-
10/2006 |
4 | Steroid 17-alpha-Hydroxylase (17 alpha Hydroxylase)IBA
02/2010
-
10/2006 |
3 | Phytoestrogens (Phytoestrogen)IBA
01/2014
-
01/2013 |
3 | Aromatase InhibitorsIBA
06/2013
-
09/2008 |
3 | Estrogens (Estrogen)FDA Link
09/2008
-
08/2003 |
3 | EnzymesIBA
02/2008
-
02/2005 |
2 | Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
01/2019
-
10/2002 |
2 | ResveratrolIBA
01/2019
-
01/2014 |
2 | 8-prenylnaringeninIBA
01/2014
-
06/2013 |
2 | Messenger RNA (mRNA)IBA
01/2014
-
09/2008 |
2 | GenisteinIBA
01/2014
-
06/2013 |
2 | tetrabromobisphenol AIBA
12/2013
-
12/2005 |
2 | bisphenol AIBA
12/2013
-
12/2005 |
2 | TamoxifenFDA LinkGeneric
06/2013
-
01/2013 |
2 | DioxinsIBA
07/2012
-
08/2003 |
2 | Fura-2 (Fura 2)IBA
04/2010
-
04/2010 |
2 | Coloring Agents (Dyes)IBA
04/2010
-
04/2010 |
2 | 2,2',4,4'-tetrabromodiphenyl etherIBA
04/2010
-
06/2007 |
2 | LactonesIBA
02/2010
-
09/2008 |
2 | Hormones (Hormone)IBA
02/2010
-
09/2008 |
2 | rofecoxib (Vioxx)FDA Link
02/2010
-
04/2009 |
2 | LuciferasesIBA
09/2008
-
10/2002 |
2 | PhenolsIBA
10/2006
-
12/2005 |
2 | Vitellogenins (Vitellogenin)IBA
12/2005
-
10/2002 |
1 | puag-haadIBA
01/2019 |
1 | pterostilbeneIBA
01/2019 |
1 | pinostilbeneIBA
01/2019 |
1 | Environmental Pollutants (Pollutants, Environmental)IBA
03/2016 |
1 | naringeninIBA
01/2014 |
1 | CalciumIBA
01/2014 |
1 | CoumestrolIBA
01/2014 |
1 | QuercetinIBA
01/2014 |
1 | steroidogenic acute regulatory proteinIBA
01/2014 |
1 | Proteins (Proteins, Gene)FDA Link
12/2013 |
1 | phthalic acid (phthalate)IBA
12/2013 |
1 | multidrug resistance-associated protein 1IBA
12/2013 |
1 | Subfamily B ATP Binding Cassette TransporterIBA
12/2013 |
1 | perfluorooctanoic acidIBA
12/2013 |
1 | Member 1 Subfamily B ATP Binding Cassette TransporterIBA
12/2013 |
1 | Hazardous Substances (Hazardous Materials)IBA
12/2013 |
1 | perfluorooctane sulfonic acidIBA
12/2013 |
1 | Letrozole (Femara)FDA LinkGeneric
06/2013 |
1 | Selective Estrogen Receptor Modulators (SERM)IBA
06/2013 |
1 | Estrogen Receptor alphaIBA
06/2013 |
1 | LigandsIBA
07/2012 |
1 | N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA
12/2011 |
1 | Neurotransmitter Agents (Neurotransmitter)IBA
12/2011 |
1 | 2,2',4,4',5-brominated diphenyl etherIBA
04/2010 |
1 | 5-OH-BDE-47IBA
04/2010 |
1 | pentabrominated diphenyl ether 100IBA
04/2010 |
1 | hexabrominated diphenyl ether 153IBA
04/2010 |
1 | 2,3-bis(3'-hydroxybenzyl)butyrolactone (enterolactone)IBA
02/2010 |
1 | CytochromesIBA
02/2010 |
1 | StilbenesIBA
04/2009 |
1 | Corn Oil (Oil, Corn)IBA
02/2009 |
1 | SolutionsIBA
02/2009 |
1 | Androgen Receptors (Androgen Receptor)IBA
09/2008 |
1 | Androgen Antagonists (Antiandrogens)IBA
09/2008 |
1 | Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
03/2008 |
1 | CatecholaminesIBA
06/2007 |
1 | 2,4,6-tribromoanisoleIBA
12/2005 |
1 | Flame Retardants (Fire Retardants)IBA
12/2005 |
1 | Ether (Diethyl Ether)IBA
12/2005 |
1 | Estrogen ReceptorsIBA
12/2005 |
1 | 2,4,6-tribromophenolIBA
12/2005 |
1 | 4-bromophenolIBA
12/2005 |
1 | dibromopropaneIBA
12/2005 |
1 | tributyl phosphate (TBP)IBA
12/2005 |
1 | Dinoprostone (PGE2)FDA Link
02/2005 |
1 | AndrogensIBA
02/2005 |
1 | Interleukin-6 (Interleukin 6)IBA
02/2005 |
1 | FlavonoidsIBA
11/2004 |
1 | Catechol EstrogensIBA
10/2004 |
1 | XenobioticsIBA
01/2004 |
1 | Indicators and Reagents (Reagents)IBA
08/2003 |
1 | Cytochrome P-450 CYP1A1 (CYP1A1)IBA
10/2002 |